The Highest Standard in Clinical Data Science

USA, Belgium
Joined November 2011
Behind every pink ribbon is a story, a loved one, a life touched by breast cancer. 🎀💗 This October, the #IDDI team wore pink to raise awareness, stand with those affected, and support continued progress in cancer care. #PinkOctober #BreastCancerAwareness
4
🎥 Missed our webinar with Marvin EDC? Explore how to bridge the gap between adaptive trial design and execution, aligning data, systems, and workflows to support timely decisions. ▶️ Watch the recording: iddi.com/resources/project-o… #AdaptiveTrials #ClinicalTrials #Oncology
12
350+ IDMCs. 1,000+ meetings. 1,400+ reports. Bring decades of independent expertise to your critical trial reviews with IDDI. Strengthen your IDMC strategy. Start here: go.iddi.com/premium-idmc-ser… #ClinicalTrial
8
Surrogate endpoints can accelerate drug development. But validation is critical. #IDDI's experts helped establish the meta-analytical framework informing regulatory evaluation. Today, we bring that expertise to strategic clinical trial consulting. Explore: iddi.com/services/strategic-…
5
⏳ 2 days to go! An adaptive trial design is only as effective as its execution. Join #IDDI & Marvin EDC to explore how to turn adaptive trial decisions into action, using oncology dose optimization as a practical case. 📅 Oct 15 | 4pm CEST Register: register.gotowebinar.com/reg…
12
In #ophthalmology trials, meaningful evidence is rarely straightforward. Specialized endpoints, variable measurements & complex disease progression can shape trial design & analysis. On #WorldSightDay, explore how to run more efficient ophthalmology trials iddi.com/resources/5-data-dr…
4
Not every question an IDMC faces can be anticipated. Effective #IDMC oversight requires planning, statistical support, reliable reporting, and the flexibility to respond as evidence evolves. Explore practical considerations in our eBook "Mastering IDMCs": go.iddi.com/ebook-mastering-…
1
19
Every step, every helping hand, and every contribution was for the same reason: children with cancer 💛 Proud of our #IDDI team who ran, walked, and volunteered at #RunToKick 2026! Together with 5,000 participants, €2.5M was raised for childhood cancer research—a new record! 🎉
4
🎀Behind every advance in #breastcancer care is evidence built patient by patient, data point by data point. This #BreastCancerAwarenessMonth, we recognize the patients, families, healthcare professionals, researchers behind progress & the evidence helping drive better decisions.
6
Accelerated timelines put data readiness to the test. Ep. 3 explores how data standards, transparency & EDC support trustworthy evidence▶️ iddi.com/resources/when-meth… Discover how methodology, data & technology come together to operationalize #adaptivetrials: register.gotowebinar.com/reg…
24
What is your trial really telling you? Effective #IDMC oversight helps put evolving evidence into context, protect patients, and preserve trial integrity. #IDDI's Founder & CSO MarcBuyse shares lessons from decades of IDMC experience. ▶️ Watch:  go.iddi.com/idmc-insights-ro…
15
From breast to rectal cancer, #IDDI’s longstanding collaboration with @JulesBordet reflects our deep #oncology and biostatistical expertise—turning complex real-world data into meaningful evidence. Planning an #oncology clinical trial? Contact our experts: iddi.com
16
🧡 Safe care for life. This #WorldPatientSafetyDay focuses on safe care for people living with noncommunicable diseases—conditions that often require lifelong care. At #IDDI, we’re proud to help build reliable evidence that supports better, safer care!
9
Operationalizing adaptive trials: Is your team aligned? Using #oncology dose optimization as an example, join our #IDDI webinar to explore how methodology, data, technology, and operations can support critical decisions. Project Optimus Meets EDC | 15 Oct: register.gotowebinar.com/reg…
5
#IDDI strengthens leadership team to advance #clinicaldata science. We welcome Maud Larochette as our new CEO, succeeding Marc Buyse, who continues as CSO. Tara Kervin becomes Chief Strategy Officer & Judith De Kempeneer VP of Customer Experience. More: iddi.com/about-us/news/iddi-…
1
9
Your interim analysis is planned. Is your trial data ready? In Ep. 2 of the #IDDI podcast series When Methodology Meets Technology, discover why group sequential designs require aligned statistics, EDC, and data workflows. ▶️ Watch it here: go.iddi.com/l/1100512/2026-0…
6
For several years, IDDI has proudly joined the #KickCancer Run. On 27 September, our #IDDI OncoWarriors will run again to support childhood cancer research 💛 Meet our runners, follow our progress and support the team: runtokick.be/fr/team/iddi-on… Every step and donation counts!
1
10
#DYK | Standard tables and listings don’t always tell the full story behind an emerging signal. See how experienced #SDAC support can help #IDMCs turn complex interim data into clear, reliable information and focus on the evidence that matters most 👉 go.iddi.com/how-an-experienc…
1
9
Adaptive trials need sound statistics, accurate data & technology that can deliver both. Learn how with IDDI & Marvin experts in Ep.1 of "When Methodology Meets Technology": iddi.com/resources/when-meth… Continue the convo at "Project Optimus Meets EDC", 15 Oct: go.iddi.com/l/1100512/2026-0…
1
12
What does a better treatment mean for a patient? More time. Fewer side effects. Better quality of life. #IDDI uses #GPC and #NetTreatmentBenefit to bring patient-relevant outcomes together—helping sponsors design more meaningful, efficient trials. More: iddi.com/eclinical-technolog…
1
12